Related Experiment Video
Updated: Oct 25, 2025

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium
Published on: February 14, 2022
High-Dose Daptomycin Is Well Tolerated via 2-Minute IV Push Administration
Christian M Gill1, Rachel M Kenney1, Charles T Makowski1
1Henry Ford Hospital, Detroit, MI, USA.
Background:
The purpose of this study was to evaluate the safety of administering high-dose daptomycin (HDD; > 6 mg/kg actual body weight) as a 2-minute intravenous (IV) push (IVP) compared to traditional 30-minute IV piggyback (IVPB) infusion.
Methods:
Retrospective cohort study comparing patients receiving HDD as an IVP or IVPB infusion. The primary outcome was the proportion of patients with a documented infusion-related reaction (IRR) to daptomycin.
Results:
Three hundred patients were included in the final analysis, 200 patients received IVP, and 100 patients received IVPB representing a total of 1697 administrations. Median (IQR) daptomycin dose was IVP 700 mg (550-900) and IVPB 700 mg (600-900), with mg/kg doses of 8.2 (7.9-10) and 8.3 (8-10), respectively. After adjudication, IRR occurred in 1% of subjects in each treatment group.
Conclusions:
This study provides data in more than 1100 administrations of HDD administered via IVP. Infusion-related reactions were documented in 1% of patients regardless of infusion method, suggesting comparable safety to traditional infusion methods. This practice may be useful during fluid shortage and in the outpatient setting.
Insights
High-dose daptomycin (HDD) administered via intravenous push (IVP) showed comparable safety to traditional intravenous piggyback (IVPB) infusions. Infusion-related reactions occurred in only 1% of patients, regardless of the infusion method.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Infectious Diseases
Background:
- High-dose daptomycin (HDD) is increasingly used.
- Traditional administration involves a 30-minute intravenous piggyback (IVPB) infusion.
- Alternative, faster administration methods are being explored for efficiency and patient convenience.
Purpose of the Study:
- To evaluate the safety of administering HDD via a rapid 2-minute intravenous push (IVP).
- To compare the incidence of infusion-related reactions (IRRs) between IVP and IVPB methods for HDD.
Main Methods:
- Retrospective cohort study design.
- Compared patients receiving HDD via IVP versus IVPB.
- Primary outcome: proportion of patients with documented IRR to daptomycin.
Main Results:
- 300 patients included (200 IVP, 100 IVPB) with 1697 administrations.
- Median doses were comparable between groups (approx. 700 mg, >8 mg/kg).
- IRRs occurred in 1% of patients in both the IVP and IVPB groups.
Conclusions:
- Administering HDD via a 2-minute IVP is safe and comparable to traditional IVPB infusion.
- Low incidence of IRRs (1%) suggests this method is well-tolerated.
- IVP administration of HDD may be beneficial in fluid-restricted settings and outpatient care.
More Related Videos
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Estimation of k and VD of Aminoglycosides
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Desensitization and Tachyphylaxis

